Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-06T08:23:09.880Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk Factors for Colonization With Vancomycin-Resistant Enterococci in a Melbourne Hospital

Published online by Cambridge University Press:  02 January 2015

C. Raina MacIntyre ,
Marianne Empson ,
Claire Boardman ,
Doungkamol Sindhusake ,
Julie Lokan  and
Graham V. Brown
C. Raina MacIntyre*
Affiliation:
National Centre for Immunisation Research, New Children's Hospital, Westmead, New South Wales Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Victoria
Marianne Empson
Affiliation:
Department of Microbiology, The Royal Melbourne Hospital, Victoria Department of Public Health and Community Medicine, Westmead Hospital, New South Wales, Australia
Doungkamol Sindhusake
Affiliation:
Department of Public Health and Community Medicine, Westmead Hospital, New South Wales, Australia
Julie Lokan
Affiliation:
Department of Anatomical Pathology, Austin and Repatriation Hospital, Victoria
Graham V. Brown
Affiliation:
Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Victoria
*
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Disease, New Children's Hospital, Westmead, NSW 2145, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine risk factors for colonization with vancomycin-resistant enterococci (VRE) in a hospital outbreak.

Design:

Outbreak investigation and case-control study.

Setting:

A referral teaching hospital in Melbourne, Australia.

Participants:

Cases were inpatients colonized (with or without clinical disease) with VRE between July 26 and November 28, 1998; controls were hospitalized patients without VRE.

Methods:

Five cases of VRE were identified between July 26 and November 8, 1998, by growth of VRE from various sites. Active case finding by cultures of rectal swabs from patients surveyed in wards was commenced on July 26, after the first isolate of VRE.

Results:

There were 19 cases and 66 controls. All the VRE identified were vanB, and all were Enterococcus faecium. One molecular type predominated (18/19 cases). In a logistic-regression model, being on the same ward as a VRE case was the highest risk factor (odds ratio [OR], 82; 95% confidence interval [CI95], 5.7-1,176; P=.001). Having more than five antibiotics (OR 11.9; CI95, 1.1-129.6; P<.05), use of metronidazole (OR 10.9; CI95, 1.7-69.8; P=.01), and being a medical patient (OR 8.1; CI95,1.4-47.6; P<.05) also were significant. Intensive care unit admission was associated with decreased risk (OR, 0.1; CI95, 0.01-0.8; P<.05).

Conclusion:

Our findings are consistent with an acute hospital outbreak. Monitoring and control of antibiotic use, particularly metronidazole, may reduce VRE in our hospital. Ongoing surveillance and staff education also are necessary.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 10 , October 2001 , pp. 624 - 629
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Leclercq, R, Derlot, E, Duval, J, Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium . N Engl J Med 1988;319:157–161.CrossRefGoogle ScholarPubMed
2. Uttley, A, Collins, C, Naidoo, J, George, R. Vancomycin-resistant entero-cocci. Lancet 1999;1:57–58.Google Scholar
3. Bell, J, Turnidge, J, Coombs, G, O'Brien, F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Communicable Diseases Intelligence 1998;22:249–252.Google ScholarPubMed
4. Grayson, ML, Grabsch, EA, Johnson, PD, Olden, D, Aberline, M, Li, HY, et al. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 1999;171:133–136.CrossRefGoogle Scholar
5. Bonten, MJ, Slaughter, S, Hayden, MK, Nathan, C, van Voorhis, J, Weinstein, RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 1998;26:2001–2004.CrossRefGoogle ScholarPubMed
6. Christenson, JC, Korgenski, EK, Jenkins, E, Daly, JA. Detection of vancomycin-resistant enterococci colonization in a children's hospital. Am J Infect Control 1998;26:569–571.CrossRefGoogle ScholarPubMed
7. Quale, J, Landman, D, Atwood, E, Kreiswirth, B, Willey, BM, Ditore, V, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996;24:372–379.CrossRefGoogle ScholarPubMed
8. Toye, B, Shymanski, J, Bobrowska, M, Woods, W, Ramotar, K. Clinical and epidemiologic significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol 1997;35:3166–3170.CrossRefGoogle ScholarPubMed
9. Bonten, MJ, Slaughter, S, Ambergen, AW, Hayden, MK, van Voorhis, J, Nathan, C, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127–1132.CrossRefGoogle ScholarPubMed
10. Nourse, C, Murphy, H, Byrne, C, O'Meara, A, Breatnach, F, Kaufmann, M, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998;157:20–27.CrossRefGoogle Scholar
11. Moreno, F, Grota, P, Crisp, C, Magnon, K, Melcher, GP, Jorgensen, JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234–1237.CrossRefGoogle Scholar
12. Dever, LL, China, C, Eng, RH, O'Donovan, C, Johanson, WG Jr. Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage. Am J Infect Control 1998;26:40–46.CrossRefGoogle Scholar
13. Boyce, JM, Opal, SM, Potter-Bynoe, G, LaForge, RG, Zervos, MJ, Furtado, G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032–1039.CrossRefGoogle ScholarPubMed
14. Edmond, MB, Ober, JF, Weinbaum, DL, Pfaller, MA, Hwang, T, Sanford, MD, et al. Vancomycin-resistant Enterococcus faecium bacteraemia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.CrossRefGoogle ScholarPubMed
15. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23:87–94.CrossRefGoogle Scholar
16. Carbon, C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 1999;44:31–36.CrossRefGoogle ScholarPubMed
17. Health and Community Services Standing Committee on Infection Control (SCIC). Guidelines for the management of patients with vancomycin-resistant enterococci (VRE) infection/colonisation. Melbourne, Australia: Department of Health and Community Services; 1996.Google Scholar
18. Kohner, PC, Patel, R, Uhl, JR, Garin, KM, Hopkins, MK, Wegener, LT, et al. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. J Clin Microbiol 1997;35:3258–3263.CrossRefGoogle ScholarPubMed
19. Dutka-Malen, S, Evers, S, Courvalin, P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995;33:24–27.CrossRefGoogle Scholar
20. Patel, R, Uhl, JR, Kohner, P, Hopkins, MK, Cockerill, FR 3rd. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol 1997;35:703–707.CrossRefGoogle ScholarPubMed
21. Miranda, AG, Singh, KV, Murray, BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991;29:2752–2757.CrossRefGoogle ScholarPubMed
22. Tenover, FC, Arbeit, RD, Goering, RV, Mickelsen, PA, Murray, BE, Persing, DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.CrossRefGoogle ScholarPubMed
23. Bopp, LH, Schoonmaker, DJ, Baltch, AL, Smith, RP, Rite, WJ. Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State. Am J Infect Control 1999;27:411–417.CrossRefGoogle ScholarPubMed
24. Pearce, CL, Evans, MK, Peters, SM, Cole, MF. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital. Am J Infect Control 1998;26:563–568.CrossRefGoogle Scholar
25. Karlowsky, JA, Zhanel, GG, Hoban, DJ. Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Diagnostic Microbiology & Infectious Disease 1999;35:1–7.CrossRefGoogle ScholarPubMed
26. Brown, AR, Amyes, SG, Paton, R, Plant, WD, Steverson, GM, Winney, RJ, et al. Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. J Hosp Infect 1998;40:115–124.CrossRefGoogle Scholar
27. Wendt, C, Ludwig, P, Rath, A. Methodology of outbreak investigation demonstrated by an outbreak of infections with vancomycin-resistant enterococci. Hygiene + Medizin 1999;24:402–409.Google Scholar
28. Roghmann, MC, McCarter, RJ Jr, Brewrink, J, Cross, AS, Morris, JG Jr. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 1997;25:1056–1059.CrossRefGoogle ScholarPubMed
29. Garbutt, JM, Littenberg, B, Evanoff, BA, Sahm, D, Mundy, LM. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile . Infect Control Hosp Epidemiol 1999;20:664–670.CrossRefGoogle ScholarPubMed
30. Dartnell, JGA, Emerson, N, Yuksel, E, Moulds, RFW. Route of administration of antibiotics: a hospital-wide evaluation. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Vol. 4. Melbourne, Australia; June 1997.Google Scholar
31. Pestotnik, SL, Classen, DC, Evans, RS, Burke, JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884–890.CrossRefGoogle ScholarPubMed
32. Evans, RS, Classen, DC, Pestotnik, SL, Clemmer, TP, Weaver, LK, Burke, JP. A decision support tool for antibiotic therapy. Proc Annu Symp Comput Appl Med Care 1995:651–655.Google ScholarPubMed
33. Brodie, DC, Smith, WE, Hlynka, JN. Model for drug usage review in a hospital. Am J Hosp Pharm 1977;34:251–254.Google ScholarPubMed
34. Bergman, U, Popa, C, Tomson, Y, Wettermark, B, Elnarson, TR, Aberg, H, et al. Drug utilization 90%—a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998;54:113–118.CrossRefGoogle Scholar
35. Ostrowsky, BE, Venkataraman, L, EMC, DA, Gold, HS, DeGirolami, PC, Samore, MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999;159:1467–1472.CrossRefGoogle ScholarPubMed
36. Austin, DJ, Bonten, MJM, Weinstein, RA, Slaughter, S, Anderson, RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. The Proceedings of the National Academy of Sciences of the United States of America 1999;96:6908–6913.Google ScholarPubMed
37. Carmeli, Y, Samore, MH, Huskins, WC. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 1999;159:2461–2468.CrossRefGoogle ScholarPubMed
38. Malathum, K, Murray, BE. Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options. Drug Resist Updates 1999;2:224–243.CrossRefGoogle ScholarPubMed
39. Montecalvo, MA, Jarvis, WR, Uman, J, Shays, DK, Petrullo, C, Rodney, K, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269–272.CrossRefGoogle Scholar